Antiangiogenic tumour therapy: will it work?
- 1 June 1998
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 19 (6) , 216-222
- https://doi.org/10.1016/s0165-6147(98)01211-5
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Thalidomide may impede cell migration in primates by down-regulating integrin β-chains: potential therapeutic utility in solid malignancies, proliferative retinopathy, inflammatory disorders, neointimal hyperplasia, and osteoporosisMedical Hypotheses, 1997
- Assessing tumor angiogenesis using macromolecular MR imaging contrast mediaJournal of Magnetic Resonance Imaging, 1997
- TNP-470 (AGM-1470): Mechanisms of action and early clinical developmentEuropean Journal Of Cancer, 1996
- Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluationEuropean Journal Of Cancer, 1996
- Acute inflammatory changes in subcutaneous microtumors in the ears of mice induced by intravenous CM101 (GBS toxin)Zeitschrift für Krebsforschung und Klinische Onkologie, 1996
- Use of von Willebrand Factor Promoter to Transduce Suicidal Gene to Human Endothelial Cells, HUVECHuman Gene Therapy, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- VasculogenesisAnnual Review of Cell and Developmental Biology, 1995
- Angiogenesis in the developing corpus luteum of pregnant rats: A stereologic and autoradiographic studyThe Anatomical Record, 1988